PMC10415786_01
Findings of chest computed tomography (CT) on admission. Ground-glass opacities and infiltrative shadows in both the upper lobes and the right lower lobe.
gr1.jpg
PMC10415786_01_gr1.jpg
fig1
Chest radiography showed normal findings, whereas chest computed tomography (CT) (Fig. 1) showed ground-glass opacities and infiltrative shadows in both the upper lobes and the right lower lobe.
Findings of chest computed tomography (CT) on the eighth day of hospitalization. Worsening of the ground-glass opacities and infiltrative shadows, spreading throughout both lungs and surpassing the initial observations upon admission.
gr2.jpg
PMC10415786_01_gr2.jpg
fig2
The chest CT scan (Fig. 2) revealed worsening of the ground-glass opacities and infiltrative shadows, spreading throughout both lungs and surpassing the initial observations upon admission.
Therapeutic course of Pneumocystis pneumonia. TMP-SMX, trimethoprim-sulfamethoxazole; CZP, certolizumab pegol; MTX, methotrexate; m-PSL, methylprednisolone; PSL, prednisolone; CRP, C-reactive protein; LDH, lactate dehydrogenase.
gr3.jpg
PMC10415786_01_gr3.jpg
fig3
Additionally, considering the possibility of methotrexate-associated pneumonia and PCP, the patient received corticosteroid therapy and trimethoprim-sulfamethoxazole (TMP-SMX) at 960 mg/4800 mg per day for 3 weeks (Fig. 3).